These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3602074)

  • 1. [The polymorphism of drugs in powders and tablets. 4. The effect of the polymorphism of drugs on the physical properties and drug release of phenobarbital tablets].
    Szabó-Réveśz P; Pintye-Hódi K; Miseta M; Selmeczi B; Kedvessy G; Traue J; Kala H; Wenzel U
    Pharmazie; 1987 Mar; 42(3):179-81. PubMed ID: 3602074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [On the Polymorphism of barbiturates in powders and tablets. Part 4: the dissolution of barbital B and barbital A (modifications I and III and their release from tablets (author's transl)].
    Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1980 Jan; 35(1):32-5. PubMed ID: 7384174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of water-soluble macromolecular binders on the properties of fluidized bed dried granulates and tablets made from them].
    Voigt R; Richter M
    Pharmazie; 1988 Mar; 43(3):191-4. PubMed ID: 3380862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The polymorphism of drugs in powders and tablets. 1. The preparation and characterization of polymorphic modifications of phenobarbital].
    Traue J; Kala H; Wenzel U; Wiegeleben A; Pintye-Hódi K; Szabó-Révész P; Miseta M; Selmeczi B; Kedvessy G
    Pharmazie; 1987 Feb; 42(2):86-9. PubMed ID: 3602065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmaceutical studies on physical properties of solid form drugs. IV. Behavior of powders in tabletting (author's transl)].
    Kigasawa K; Iimura H; Tanizaki A; Sugahara S; Watabe K; Sugimura H; Shimizu H
    Yakugaku Zasshi; 1979 Jul; 99(7):723-9. PubMed ID: 544790
    [No Abstract]   [Full Text] [Related]  

  • 6. Investigation of some materials as dry binders for direct compression in tablet manufacture. Part 7: Formulation and evaluation of ascorbic acid and phenobarbitone tablets.
    Asker AF; Saied KM; Abdel-Khalek MM
    Pharmazie; 1975 Jul; 30(7):466-70. PubMed ID: 1178765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of a prolonged-release tablet formulation of diclofenac sodium. Part 1: Using chitosan.
    Acartürk F
    Pharmazie; 1989 Aug; 44(8):547-9. PubMed ID: 2594826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of incorporation technics of water soluble macromolecular binders on the properties of fluidized-bed dried granules].
    Richter M; Rahn HW; Voigt R
    Pharmazie; 1989 Jan; 44(1):43-6. PubMed ID: 2727029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of particle size of acetylsalicylic acid on the dissolution rate of tablets].
    Cid E; Jaminet F
    Farmaco Prat; 1972 May; 27(5):298-304. PubMed ID: 5025713
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the compression behaviour of spray-dried sulphathiazole (author's transl)].
    Kala H; Moldenhauer H; Giese R; Kedvessy G; Selmeczi B; Pintye-Hódi K
    Pharmazie; 1982 Feb; 37(2):129-31. PubMed ID: 7071118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of the influence of formulation factors and processing techniques on the dissolution rates of hydrochlorothiazide tablets.
    Seth P
    Pharm Acta Helv; 1972; 47(6):457-65. PubMed ID: 5044950
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of cellulose II powders as a potential multifunctional excipient in tablet formulations.
    de la Luz Reus Medina M; Kumar V
    Int J Pharm; 2006 Sep; 322(1-2):31-5. PubMed ID: 16828996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dry coating of micronized API powders for improved dissolution of directly compacted tablets with high drug loading.
    Han X; Ghoroi C; Davé R
    Int J Pharm; 2013 Feb; 442(1-2):74-85. PubMed ID: 22921376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo characteristics of some commercial phenobarbital tablets.
    Sylvestri MF; Ueda CT
    Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):492-7. PubMed ID: 528095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the polymorphism of barbiturates in powders and tablets. Part 1: Crystal optical studies on, and melting behaviour of barbital (author's transl)].
    Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1979; 34(3):164-7. PubMed ID: 450956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of dry binding materials for the direct compression of phenylbutazone].
    Miseta M; Pintye-Hódi K; Szabó-Révész P; Selmeczi B; Kedvessy G
    Pharmazie; 1985 Jul; 40(7):477-8. PubMed ID: 4048253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of microcrystalline cellulose on the properties of phenobarbital tablets].
    Szabóné Révész P; Pintyéné Hódi K; Miseta M; Selmeczi B
    Acta Pharm Hung; 1984 Jul; 54(4):181-6. PubMed ID: 6485812
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the compressibility of micronized celluloses of the Avicel and the Heweten type (author's transl)].
    Kedvessy G; Selmeczi B; Deme-Rápó J; Kala H; Moldenhauer H; Giese R
    Pharmazie; 1982 Jan; 37(1):29-30. PubMed ID: 7071109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical properties and dissolution profiles of acetaminophen and acetylsalicyclic acid tablets made from sucrose-based vehicles.
    Elsabbagh HM; Ghanem AH; Elshaboury MH
    Pharmazie; 1981; 36(7):488-92. PubMed ID: 7280001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of chlorthalidone polymorphs in raw materials and tablets and the effect of forms I and II on the dissolution properties of drug products.
    Bonfilio R; Leal JS; Santos OM; Pereira GR; Doriguetto AC; de Araújo MB
    J Pharm Biomed Anal; 2014 Jan; 88():562-70. PubMed ID: 24216278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.